SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

The biotech firm said it is progressing towards a Phase II clinical trial of its antiviral drug NV-387 for the Bundibugyo ...

M1 and StarHub's older 5G networks already retired; Singtel and Simba have not said when they will complete the transition ...

Firefly Aerospace posts 135% revenue growth while Rocket Lab pursues a game-changing $8 billion acquisition, here’s how their financials and risks compare.

DNB begins activating an additional 100MHz of 3.5GHz spectrum, doubling 5G network capacity, as U Mobile officially exits its ...

The development of the 6G standard is entering a more concrete phase. At the June 2026 3GPP RAN Plenary in Singapore, the industry advanced several key areas under study and finalized the timeline for ...

The FDA granted priority review to a supplemental biologics license application for Enspryng for thyroid eye disease, ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

As rights fees continue to climb and advertising markets fragment, margin expansion won’t come from doing the same thing more ...

Abstract: Inverse synthetic aperture radar (ISAR) and optical image fusion aims to generate a composite image that simultaneously emphasizes the prominent contours of spacecraft from optical images ...

Earliest quasar variability ever detected shows a 630-million-solar-mass black hole at cosmic dawn already had an orderly ...

SHELTON, CT / ACCESS Newswire / June 22, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today announced ...